非O血型与口服雌激素在绝经后女性静脉血栓栓塞风险中的协同作用：ESTHER研究。 - Suppr

Suppr

超能文献

Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.

作者信息

Canonico Marianne, Olié Valérie, Carcaillon Laure, Tubert-Bitter Pascale, Scarabin Pierre-Yves

出版信息

Thromb Haemost. 2008 Jan;99(1):246-8. doi: 10.1160/TH07-09-0536.

DOI:10.1160/TH07-09-0536

PMID:18217166

Abstract

摘要

相似文献

Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.

Thromb Haemost. 2008 Jan;99(1):246-8. doi: 10.1160/TH07-09-0536.

Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.

Clin Pharmacol Ther. 2011 Jan;89(1):60-4. doi: 10.1038/clpt.2010.241. Epub 2010 Nov 24.

Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.

Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2807-12. doi: 10.1161/01.ATV.0000245792.62517.3b. Epub 2006 Sep 14.

Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.

Thromb Haemost. 2008 Jan;99(1):223-8. doi: 10.1160/TH07-08-0515.

[Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: comparison of a new kind of transdermal estradiol treatment with oral therapy with conjugated estrogens].

Zentralbl Gynakol. 1995;117(10):540-8.

Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.

Maturitas. 2009 Oct 20;64(2):136-8. doi: 10.1016/j.maturitas.2009.08.013. Epub 2009 Sep 25.

Estradiol associated with lower thrombotic risk than conjugated equine estrogens when used as oral HRT.

Menopause Int. 2013 Dec;19(4):145.

Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.

Circulation. 2007 Feb 20;115(7):840-5. doi: 10.1161/CIRCULATIONAHA.106.642280.

Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women.

Curr Opin Hematol. 2010 Sep;17(5):457-63. doi: 10.1097/MOH.0b013e32833c07bc.

[Hormone therapy and risk for venous thromboembolism in postmenopausal women].

Rev Prat. 2005 Feb 28;55(4):389-92.

引用本文的文献

Biomarkers, menopausal hormone therapy and risk of venous thrombosis: The Women's Health Initiative.

Res Pract Thromb Haemost. 2018 Apr 17;2(2):310-319. doi: 10.1002/rth2.12100. eCollection 2018 Apr.

ABO blood types associated with the risk of venous thromboembolism in Han Chinese people: A hospital-based study of 200,000 patients.

Sci Rep. 2017 Mar 6;7:42925. doi: 10.1038/srep42925.

Environmental and Genetic Risk Factors Associated with Venous Thromboembolism.

Semin Thromb Hemost. 2016 Nov;42(8):808-820. doi: 10.1055/s-0036-1592333. Epub 2016 Oct 20.

Inference for additive interaction under exposure misclassification.

Biometrika. 2012 Jun;99(2):502-508. doi: 10.1093/biomet/ass012. Epub 2012 Apr 2.

Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy.

J Thromb Haemost. 2013 Aug;11(8):1617-9. doi: 10.1111/jth.12309.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验